肝脏脂肪、铁沉积与纤维化的多参数MR评估:「三重筛查」简明综述
本文综述了多参数MR技术用于无创定量评估慢性肝病中肝脏脂肪、铁沉积与纤维化的原理、优势与局限。作者提出将MRI-PDFF(脂肪)、R2/R2*(铁)和肝脏硬度(纤维化)整合为单一简化的MR「三重筛查」方案,以替代肝活检提供更完整的代谢影像学评估。
要点
- MRI-PDFF可无创定量肝脏脂肪含量,替代肝活检用于NAFLD诊断与随访。
- R2与R2*可定量评估肝铁沉积,铁过载与NAFLD并存时具有负向协同效应。
- 肝脏硬度可评估肝纤维化,三者整合为简化的MR「三重筛查」方案。
核心结论
- 多参数MR技术可准确、可靠地无创检测和定量肝脏脂肪、铁沉积与纤维化。
- 这些技术可整合为单一简化的MR「三重筛查」评估,提供更完整的慢性肝病代谢影像学特征。
研究设计与样本
- 综述类文章,总结多参数MR检测和定量肝脏脂肪、铁、纤维化的概念与技术。
- 文中提出一种整合三种MR生物标志物的简化临床MR方案,未报告具体样本量与设备参数。
诊断标准与关键数值
- MRI-PDFF用于定量肝脏脂肪。
- R2和R2*用于定量肝脏铁沉积。
- 肝脏硬度用于评估肝纤维化。
临床应用与阅片要点
- 可采用简化的MR「三重筛查」方案在一次检查中同时评估肝脏脂肪、铁沉积和纤维化。
- 多参数MR生物标志物可用于慢性肝病的诊断、监测、风险分层和治疗评估。
- 铁过载与NAFLD并存时具有负向协同效应,阅片时需同时关注铁与脂肪指标。
局限性
- 本文为综述,未报告原始研究的具体样本量、敏感度、特异度或AUC等诊断效能数据。
- 文中提及所综述技术各有相对优势和局限性,但未在摘要中具体展开。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Chronic liver disease (CLD) is a common source of morbidity and mortality worldwide. Non-alcoholic fatty liver disease (NAFLD) serves as a major cause of CLD with a rising annual prevalence. Additionally, iron overload can be both a cause and effect of CLD with a negative synergistic effect when combined with NAFLD. The development of state-of-the-art multiparametric MR solutions has led to a change in the diagnostic paradigm in CLD, shifting from traditional liver biopsy to innovative non-invasive methods for providing accurate and reliable detection and quantification of the disease burden. Novel imaging biomarkers such as MRI-PDFF for fat, R2 and R2* for iron, and liver stiffness for fibrosis provide important information for diagnosis, surveillance, risk stratification, and treatment. In this article, we provide a concise overview of the MR concepts and techniques involved in the detection and quantification of liver fat, iron, and fibrosis including their relative strengths and limitations and discuss a practical abbreviated MR protocol for clinical use that integrates these three MR biomarkers into a single simplified MR assessment. Multiparametric MR techniques provide accurate and reliable non-invasive detection and quantification of liver fat, iron, and fibrosis. These techniques can be combined in a single abbreviated MR "Triple Screen" assessment to offer a more complete metabolic imaging profile of CLD.
引用
- Low, Ferguson, Locas, et al. Multiparametric MR assessment of liver fat, iron, and fibrosis: a concise overview of the liver "Triple Screen". Abdom Radiol (NY). 2023. PMID: 37041393. doi:10.1007/s00261-023-03887-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。